-
C648020-100mg(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.Form:Solid
-
C648020-10mg(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.Form:Solid
-
C648020-25mg(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.Form:Solid
-
C648020-50mg(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.Form:Solid
-
C648020-5mg(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.Form:Solid
-
C655256-1ml(R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC 50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.
-
A646636-10mgACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC 50 value of 3.2 nM.Form:SolidIC50& Target:CXCR7
-
A646636-5mgACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC 50 value of 3.2 nM.Form:SolidIC50& Target:CXCR7
-
A654672-1mlACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC 50 value of 3.2 nM.IC50& Target:CXCR7
-
A646614-10mgACT-660602 is an orally active antagonist of chemokine receptor ( CXCR3 ) with an IC 50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases researchIn
-
A646614-25mgACT-660602 is an orally active antagonist of chemokine receptor ( CXCR3 ) with an IC 50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases researchIn
-
A646614-5mgACT-660602 is an orally active antagonist of chemokine receptor ( CXCR3 ) with an IC 50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases researchIn